amlodipine and atorvastatin (66993-265)

Drug Facts

Product Profile

Brand Name amlodipine and atorvastatin

Generic Name amlodipine and atorvastatin

Labeler prasco laboratories

Dosage Form TABLET, COATED

Routes

ORAL

Active Ingredients

amlodipine besylate 2.5 mg/1, atorvastatin calcium trihydrate 40 mg/1

Manufacturer

Prasco Laboratories

Identifiers & Regulatory

Product NDC 66993-265

Product ID 66993-265_54ec553c-f76b-4d59-bc4e-fc519300a705

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category NDA AUTHORIZED GENERIC

Application Number NDA021540

Listing Expiration 2026-12-31

Marketing Start 2022-03-14

Pharmacologic Class

Classes

calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs] hmg-coa reductase inhibitor [epc] hydroxymethylglutaryl-coa reductase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 66993265

Hyphenated Format 66993-265

Supplemental Identifiers

RxCUI

404011 404013 597967 597971 597974 597977 597980 597984 597987 597990 597993

UPC

0366993265308 0366993267302 0366993264301 0366993268309 0366993263304 0366993273303 0366993272306 0366993271309 0366993266305 0366993269306 0366993270302

UNII

48A5M73Z4Q 864V2Q084H

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amlodipine and atorvastatin (source: ndc)

Generic Name amlodipine and atorvastatin (source: ndc)

Application Number NDA021540 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

2.5 mg/1
40 mg/1

source: ndc

Packaging

30 TABLET, COATED in 1 BOTTLE (66993-265-30)

source: ndc

Packages (1)

66993-265-30 30 TABLET, COATED in 1 BOTTLE (66993-265-30)

Ingredients (2)

amlodipine besylate (2.5 mg/1) atorvastatin calcium trihydrate (40 mg/1)

Linked Drug Pages (1)

Amlodipine and Atorvastatin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "54ec553c-f76b-4d59-bc4e-fc519300a705", "openfda": {"upc": ["0366993265308", "0366993267302", "0366993264301", "0366993268309", "0366993263304", "0366993273303", "0366993272306", "0366993271309", "0366993266305", "0366993269306", "0366993270302"], "unii": ["48A5M73Z4Q", "864V2Q084H"], "rxcui": ["404011", "404013", "597967", "597971", "597974", "597977", "597980", "597984", "597987", "597990", "597993"], "spl_set_id": ["14124e56-77ba-426d-8f5a-dbe42eda1a20"], "manufacturer_name": ["Prasco Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, COATED in 1 BOTTLE (66993-265-30)", "package_ndc": "66993-265-30", "marketing_start_date": "20220314"}], "brand_name": "Amlodipine and Atorvastatin", "product_id": "66993-265_54ec553c-f76b-4d59-bc4e-fc519300a705", "dosage_form": "TABLET, COATED", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "66993-265", "generic_name": "Amlodipine and Atorvastatin", "labeler_name": "Prasco Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Atorvastatin", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "2.5 mg/1"}, {"name": "ATORVASTATIN CALCIUM TRIHYDRATE", "strength": "40 mg/1"}], "application_number": "NDA021540", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20220314", "listing_expiration_date": "20261231"}